These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 12707997)
1. [Association between anti-phospholipid antibodies and thrombotic complications in systemic lupus erythematosus]. Nojima J Rinsho Byori; 2003 Mar; 51(3):239-47. PubMed ID: 12707997 [TBL] [Abstract][Full Text] [Related]
2. Association between the prevalence of antibodies to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications. Nojima J; Kuratsune H; Suehisa E; Futsukaichi Y; Yamanishi H; Machii T; Iwatani Y; Kanakura Y Clin Chem; 2001 Jun; 47(6):1008-15. PubMed ID: 11375285 [TBL] [Abstract][Full Text] [Related]
3. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome. Arnout J Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685 [TBL] [Abstract][Full Text] [Related]
4. The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies. Horbach DA; van Oort E; Tempelman MJ; Derksen RH; de Groot PG Thromb Haemost; 1998 Nov; 80(5):791-7. PubMed ID: 9843173 [TBL] [Abstract][Full Text] [Related]
5. [Antiphospholipid antibodies: clinical significance and biological diagnosis]. Arnoux D; Boutière B; Sanmarco M Ann Biol Clin (Paris); 2000; 58(5):557-74. PubMed ID: 11022099 [TBL] [Abstract][Full Text] [Related]
6. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies. Horbach DA; van Oort E; Donders RC; Derksen RH; de Groot PG Thromb Haemost; 1996 Dec; 76(6):916-24. PubMed ID: 8972011 [TBL] [Abstract][Full Text] [Related]
7. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus. Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489 [TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies. Pengo V; Biasiolo A; Brocco T; Tonetto S; Ruffatti A Thromb Haemost; 1996 May; 75(5):721-4. PubMed ID: 8725712 [TBL] [Abstract][Full Text] [Related]
9. Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins. Bertolaccini ML; Hughes GR; Khamashta MA Clin Lab; 2004; 50(11-12):653-65. PubMed ID: 15575307 [TBL] [Abstract][Full Text] [Related]
10. [Advanced clinical laboratory studies in the graduate school of medicine--studies on pathogenic mechanisms of anti-phospholipid syndrome]. Nojima J Rinsho Byori; 2009 Aug; 57(8):786-92. PubMed ID: 19764414 [TBL] [Abstract][Full Text] [Related]
11. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis. Ishikura K; Wada H; Kamikura Y; Hattori K; Fukuzawa T; Yamada N; Nakamura M; Nobori T; Nakano T Am J Hematol; 2004 Aug; 76(4):338-42. PubMed ID: 15282665 [TBL] [Abstract][Full Text] [Related]
12. The association of antibodies to cardiolipin, beta 2-glycoprotein I, prothrombin, and oxidized low-density lipoprotein with thrombosis in 292 patients with familial and sporadic systemic lupus erythematosus. Koskenmies S; Vaarala O; Widen E; Kere J; Palosuo T; Julkunen H Scand J Rheumatol; 2004; 33(4):246-52. PubMed ID: 15370721 [TBL] [Abstract][Full Text] [Related]
13. Detection of anti-annexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. Satoh A; Suzuki K; Takayama E; Kojima K; Hidaka T; Kawakami M; Matsumoto I; Ohsuzu F J Rheumatol; 1999 Aug; 26(8):1715-20. PubMed ID: 10451067 [TBL] [Abstract][Full Text] [Related]
15. New targeted therapies for treatment of thrombosis in antiphospholipid syndrome. Pierangeli SS; Vega-Ostertag ME; González EB Expert Rev Mol Med; 2007 Nov; 9(30):1-15. PubMed ID: 17997880 [TBL] [Abstract][Full Text] [Related]
16. The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus. Nojima J; Iwatani Y; Suehisa E; Kuratsune H; Kanakura Y Haematologica; 2006 May; 91(5):699-702. PubMed ID: 16627257 [TBL] [Abstract][Full Text] [Related]
17. Update on anti-phospholipid antibodies in SLE: the Hopkins' Lupus Cohort. Petri M Lupus; 2010 Apr; 19(4):419-23. PubMed ID: 20353980 [TBL] [Abstract][Full Text] [Related]
18. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome. Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014 [TBL] [Abstract][Full Text] [Related]
19. [Antiphospholipid and anti beta 2-glycoprotein I antibodies]. Arvieux J; Roussel B; Colomb MG Ann Biol Clin (Paris); 1994; 52(5):381-5. PubMed ID: 7856939 [TBL] [Abstract][Full Text] [Related]
20. A cross sectional study of antiphospholipid-protein antibodies in patients with venous thromboembolism. Pasquier E; Amiral J; de Saint Martin L; Mottier D Thromb Haemost; 2001 Aug; 86(2):538-42. PubMed ID: 11522000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]